Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine

M. Nocera, E. Baudin, G. Pellegriti, A. F. Cailleux, C. Mechelany-Corone, M. Schlumberger

    Research output: Contribution to journalArticlepeer-review

    107 Citations (Scopus)

    Abstract

    Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations were observed. No unexpected toxicity occurred. (C) 2000 Cancer Research Campaign.

    Original languageEnglish
    Pages (from-to)715-718
    Number of pages4
    JournalBritish Journal of Cancer
    Volume83
    Issue number6
    DOIs
    Publication statusPublished - 1 Jan 2000

    Keywords

    • Chemotherapy
    • Medullary thyroid carcinoma

    Cite this